FDA-required safety studies for drugs, devices are years overdue: KFF

Nearly 600 postmarket studies the FDA required drugmakers and devicemakers to complete after approving their products are behind schedule, according to a Sept. 18 KFF Health News analysis. Some are delayed by more than a decade, and roughly a third of ongoing studies were listed as behind schedule as of an August database download. The […] The post FDA-required safety studies for drugs, devices are years overdue: KFF appeared first on Becker's Hospital Review | Healthcare News & A...